Nephrocare Health Services Ltd (also known as NephroPlus) – Sector: Healthcare, specializing in comprehensive dialysis care in India and select international markets. – Founded: 2010 – Operations: India’s largest dialysis network with 5068 machines, serving 29,281 patients across 288 cities in 21 states and 4 UTs as of March 2025.- IPO Details: -Issue Size: ₹871.05 crore, with a fresh issue of ₹353.4 crore and an OFS of ₹517.64 crore. – Price Band: ₹438 to ₹460 per share. – Lot Size: 32 shares, requiring a minimum investment of ₹14,720. – IPO Date: Opens December 10, 2025, and closes December 12, 2025. Listing Date: Expected on December 17, 2025, on BSE and NSE.Grey Market Premium (GMP) – As of December 8, 2025, the GMP is ₹0, indicating a flat listing expectation. Note that GMP is speculative and subject to change. – The company plans to use proceeds for new clinics, debt repayment, and corporate purposes.
Grey Market Premium (GMP) – As of December 8, 2025, the GMP is ₹170, indicating a green signal. Note that GMP is speculative and subject to change. – The company plans to use proceeds for new clinics, debt repayment, and corporate purposes.
